Overview
- 165 inspections across 120 sites are on record.
- 117 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
165
Sites
120
Observations
117
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 20 May 2026 | Biologics | On file |
| Haematologic Technologies, LLC | 17 Apr 2026 | Biologics | On file |
| GSK Vaccines GmbH | 27 Feb 2026 | Biologics | On file |
| CSL Behring GmbH | 18 Feb 2026 | Biologics | On file |
| Rentschler Biopharma Inc. | 10 Dec 2025 | Biologics | On file |
Sites inspected
Merck Sharp & Dohme LLCDurham, United States1 insp.
Haematologic Technologies, LLCEssex Junction, United States1 insp.
GSK Vaccines GmbHMarburg, Germany1 insp.
CSL Behring GmbHMarburg, Germany1 insp.
Rentschler Biopharma Inc.Milford, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Prabhu P Raju17 shared
Omotunde O Osunsanmi11 shared
Jacqueline M Diaz Albert10 shared
Cynthia Jim7 shared
Charisse K Green6 shared
Travis S Bradley5 shared
Susan M Jackson5 shared
Helen B Ricalde5 shared
Roger F Zabinski4 shared
Eileen A Liu4 shared
Full investigator report
Get the verbatim findings behind Burnell M Henry's 117 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site